Moufeed Kaddoura
InvestorFounderVenture Partner at 1517 · CEO at Kenota (formerly ExVivo Labs)
United States
Find your path to Moufeed
Sign up to see every warm intro you have to Moufeed
- Paths you didn't know you had: your email and LinkedIn already hold routes to Moufeed. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Moufeed Kaddoura is the founder of Kenota Health and currently serves as CEO at Ranata Therapeutics.
CEO at Kenota (formerly ExVivo Labs)YC S16
Intro paths
Moufeed went through Y Combinator (Summer 2016) — any YC alum in your network can reach them through the YC community.
In turn, Moufeed can intro founders to Kenota (formerly ExVivo Labs)'s investors below.
Kenota (formerly ExVivo Labs)'s investors · 17
Co-founders at Kenota (formerly ExVivo Labs)

Colleagues at 1517
Frequently asked questions
- Who is Moufeed Kaddoura?
- Moufeed Kaddoura is the founder of Kenota Health and currently serves as CEO at Ranata Therapeutics.
- Where does Moufeed Kaddoura work?
- Moufeed Kaddoura is CEO of Kenota (formerly ExVivo Labs) and Venture Partner at 1517.
- What companies did Moufeed Kaddoura found?
- Moufeed Kaddoura founded Kenota (formerly ExVivo Labs).
Founder mafias
Y Combinator mafia10,594
Also came through, then founded or led a company.
University of Waterloo mafia428
Also came through, then founded or led a company.
1517 mafia2
Also came through, then founded or led a company.
About this profile. Compiled from public sources — 1517's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights























